{"anticipatedPostingDate":"2009-12","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"}],"units":"Participants"}],"description":"Number of patients who received steroids allowing successful continuation of therapy.","groups":[{"description":"Patients receiving at least 12 doses of 852A.","id":"OG000","title":"852A Treatment"}],"paramType":"NUMBER","populationDescription":"Includes patients receiving at least 12 doses of 852A study drug.","reportingStatus":"POSTED","timeFrame":"Up to Week 12","title":"Number of Patients Who Received Steroids","type":"SECONDARY","unitOfMeasure":"Participants"}